Company advancing Brilacidin as a next-generationbroad-spectrum antiviral forthe treatment of common colds and deadly coronavirusinfections WAKEFIELD, Mass., Nov. 30, 2020 (GLOBE NEWSWIRE) -- ...

Hospitals and health systems across the country are focused on their response to the coronavirus pandemic. In hot spots like Seattle or New York City, hospital CEOs are already in the midst of ...

Putting together the “Innovationeering” series has made me refresh — and occasionally reconstruct — my legacy thinking about the practice of innovation. What has also emerged is the reminder that one ...

With limited vaccine manufacturing capacity around the world, South Africa will have to prioritise its own requirements in the interest of securing access to a vaccine as a matter of national security ...

Here’s what we’ve learned – and how our understanding has evolved – since the earliest cases of the novel coronavirus were ...

From HIV/AIDS to Covid-19, global health emergencies have revived calls for compulsory licensing. But history shows that innovation, technology transfer, and manufacturing capacity—not patent waivers ...